IRF1 and melanoma: The key role of IRF1 and interferon receptor pathway in the regulation of PD-L1 has also been implied in melanoma, where putative binding sites for IRF1 have been identified in the PD-L1 promoter and abrogation of IRF1 site resulted in reduced PD-L1 levels [53, 61].